Company Filing History:
2 out of 4,897 
1 out of 112 
1 out of 3,559 
Years Active: 2012-2018
Title: Pascale Delangle: Innovator in Biochemical Solutions
Introduction
Pascale Delangle is a notable inventor based in Voiron, France. He has made significant contributions to the field of biochemistry, particularly in the development of novel compounds for medical applications. With a total of 3 patents, his work focuses on addressing critical health issues through innovative solutions.
Latest Patents
One of Delangle's latest patents is centered around cyclodecapeptide compounds for use as drugs. This invention relates to novel cyclodecapeptide compounds that are designed for the diagnosis, prevention, and treatment of neurodegenerative diseases, such as Wilson's disease and Alzheimer's disease. Additionally, these compounds are aimed at addressing poisoning from metal ions, including copper and mercury. The patent also covers pharmaceutical compositions that incorporate these compounds as active principles.
Another significant patent involves uranium-chelating peptides derived from the EF-hand calcium-binding motif. These polypeptides are designed for uranium biodetection and biodecontamination. They consist of at least one helix-loop-helix calcium-binding motif, which includes a deletion of at least two amino acids in the 12-amino-acid calcium-binding loop sequence.
Career Highlights
Throughout his career, Pascale Delangle has worked with esteemed organizations such as the Commissariat à l'Énergie Atomique et aux Énergies Alternatives and Université Joseph Fourier. His experience in these institutions has allowed him to advance his research and contribute to significant scientific advancements.
Collaborations
Delangle has collaborated with notable colleagues, including Anaïs Pujol and Pascal Dumy. These partnerships have fostered a collaborative environment that enhances innovation and research in their respective fields.
Conclusion
Pascale Delangle's contributions to biochemistry through his innovative patents highlight his commitment to addressing critical health challenges. His work continues to pave the way for advancements in medical treatments and environmental safety.